drugset / Trial / NCT07550751

Optimal Dosage of Melatonin for Preoperative Sedation in FESS

NCT07550751

Phase 4 Completed 160 enrolled Aswan University Hospital
RandomizedParallel-groupSingle-blindOther

Summary

To determine the optimal dosage of Melatonin for preoperative sedation in patients undergoing FESS.

Timeline

Start
2024-08-01
Primary completion
2025-04-30
Completion
2025-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 3 mg
Subject Melatonin Small molecule 5 mg
Subject Melatonin Small molecule 10 mg

Indications

No indication recorded.